Patents by Inventor Richard Albert Mostardi

Richard Albert Mostardi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vitamin C and vitamin K, and compositions thereof for treatment of osteolysis or prolongation of prosthetic implant
    Patent number: 9642833
    Abstract: Provided herein is a method of treating, preventing, or managing osteolysis in a subject, comprising administering to the subject a therapeutically effective amount of vitamin C, or a pharmaceutically acceptable salt, solvate, or hydrate thereof, in combination with vitamin K, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof, or a pharmaceutically acceptable salt, solvate, or hydrate thereof.
    Type: Grant
    Filed: May 19, 2015
    Date of Patent: May 9, 2017
    Assignee: IC-MEDTECH CORPORATION
    Inventors: James M. Jamison, Thomas M. Miller, Deborah R. Neal, Mark William Kovacik, Michael John Askew, Richard Albert Mostardi
  • VITAMIN C AND VITAMIN K, AND COMPOSITIONS THEREOF FOR TREATMENT OF OSTEOLYSIS OR PROLONGATION OF PROSTHETIC IMPLANT
    Publication number: 20150250760
    Abstract: Provided herein is a method of treating, preventing, or managing osteolysis in a subject, comprising administering to the subject a therapeutically effective amount of vitamin C, or a pharmaceutically acceptable salt, solvate, or hydrate thereof, in combination with vitamin K, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof, or a pharmaceutically acceptable salt, solvate, or hydrate thereof.
    Type: Application
    Filed: May 19, 2015
    Publication date: September 10, 2015
    Inventors: James M. JAMISON, Thomas M. MILLER, Deborah R. NEAL, Mark William KOVACIK, Michael John ASKEW, Richard Albert MOSTARDI
  • Vitamin C and vitamin K, and compositions thereof for treatment of osteolysis or prolongation of prosthetic implant
    Patent number: 9050265
    Abstract: Provided herein is a method of treating, preventing, or managing osteolysis in a subject, comprising administering to the subject a therapeutically effective amount of vitamin C, or a pharmaceutically acceptable salt, solvate, or hydrate thereof, in combination with vitamin K, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof, or a pharmaceutically acceptable salt, solvate, or hydrate thereof.
    Type: Grant
    Filed: July 19, 2010
    Date of Patent: June 9, 2015
    Assignee: Summa Health System
    Inventors: James M. Jamison, Thomas M. Miller, Deborah R. Neal, Mark Willam Kovacik, Michael John Askew, Richard Albert Mostardi
  • VITAMIN C AND CHROMIUM-FREE VITAMIN K, AND COMPOSITIONS THEREOF FOR TREATING AN NFKB-MEDIATED CONDITION OR DISEASE
    Publication number: 20130178522
    Abstract: Provided herein is a pharmaceutical composition comprising vitamin C and chromium-free vitamin K, and optionally one or more pharmaceutically acceptable excipient(s). Also provided herein is a chromium-free pharmaceutical composition comprising vitamin C and vitamin K, and optionally one or more pharmaceutically acceptable excipient(s). Further provided herein is a method of treating, preventing, or managing an NFKB-mediated condition, disorder, or disease, comprising administering to the subject a therapeutically effective amount of vitamin C and chromium-free vitamin K.
    Type: Application
    Filed: July 19, 2011
    Publication date: July 11, 2013
    Inventors: James M. Jamison, Deborah R. Neal, Mark William Kovacik, Michael John Askew, Richard Albert Mostardi, Karen M. McGuire, Thomas M. Miller, Tetyana V. Masyuk, Nicholas F. LaRusso
  • VITAMIN C AND VITAMIN K, AND COMPOSITIONS THEREOF FOR TREATMENT OF OSTEOLYSIS OR PROLONGATION OF PROSTHETIC IMPLANT
    Publication number: 20120184609
    Abstract: Provided herein is a method of treating, preventing, or managing osteolysis in a subject, comprising administering to the subject a therapeutically effective amount of vitamin C, or a pharmaceutically acceptable salt, solvate, or hydrate thereof, in combination with vitamin K, or a single enantiomer, a mixture of enantiomers, or a mixture of diastereomers thereof, or a pharmaceutically acceptable salt, solvate, or hydrate thereof.
    Type: Application
    Filed: July 19, 2010
    Publication date: July 19, 2012
    Applicant: SUMMA HEALTH SYSTEM
    Inventors: James M. Jamison, Thomas M. Miller, Deborah R. Neal, Mark Willam Kovacik, Michael John Askew, Richard Albert Mostardi